154
Views
1
CrossRef citations to date
0
Altmetric
Articles

Mammography use and mode of detection among breast cancer patients in Estonia

, PhD, , PhD, , PhD, , MD, , MD, , MD & , PhD show all
Pages 129-140 | Received 08 Jul 2014, Accepted 20 Nov 2014, Published online: 02 Nov 2015

References

  • Baburin, A., T. Aareleid, P. Padrik, V. Valvere, and K. Innos. 2014. Time trends in population-based breast cancer survival in Estonia: Analysis by age and stage. Acta Oncologica 53:226–34. doi:10.3109/0284186X.2013.806992.
  • De Angelis, R., M. Sant, M. P. Coleman, S. Francisci, P. Baili, D. Pierannunzio, et al. 2014. Cancer survival in Europe 1999–2007 by country and age: Results of EUROCARE-5—A population-based study. The Lancet Oncology 15:23–34. doi:10.1016/S1470-2045(13)70546-1.
  • European Commission. 2014. European health interview survey. http://epp.eurostat.ec.europa.eu/portal/page/portal/health/health_care/data/database ( accessed April 2014).
  • Finnish Cancer Registry. 2011. Cancer in Finland 2008 and 2009. Publication No. 84. Helsinki, Finland: Cancer Society of Finland.
  • Garcia, R. Z., S. C. Carvajal, A. V. Wilkinson, P. A. Thompson, J. N. Nodora, I. K. Komenaka, et al. 2012. Factors that influence mammography use and breast cancer detection among Mexican-American and African-American women. Cancer Causes Control 23:165–73. doi:10.1007/s10552-011-9865-x.
  • Giordano, L., L. von Karsa, M. Tomatis, O. Majek, C. De Wolf, L. Lancucki, et al. 2012. Mammographic screening programmes in Europe: Organization, coverage and participation. Journal of Medical Screening 19 (1):72–82. doi:10.1258/jms.2012.012085.
  • Hahn, K. M., M. L. Bondy, M. Selvan, M. J. Lund, J. M. Liff, E. W. Flagg, et al. 2007. Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. American Journal of Epidemiology 166:1035–44. doi:10.1093/aje/kwm177.
  • Kerlikowske, K., R. Walker, D. L. Miglioretti, A. Desai, R. Ballard-Barbash, and D. S. Buist. 2008. Obesity, mammography use and accuracy, and advanced breast cancer risk. JNCI Journal of the National Cancer Institute 100:1724–33. doi:10.1093/jnci/djn388.
  • Linsell, L., C. C. Burgess, and A. J. Ramirez. 2008. Breast cancer awareness among older women. British Journal of Cancer 99:1221–25. doi:10.1038/sj.bjc.6604668.
  • Lu, Y., H. Ma, K. E. Malone, S. A. Norman, J. Sullivan-Halley, B. L. Strom, et al. 2011. Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. Journal of Clinical Oncology 29:3358–65. doi:10.1200/JCO.2010.34.2048.
  • Malmgren, J. A., M. K. Atwood, and H. G. Kaplan. 2008. Increase in mammography detected breast cancer over time at a community based regional cancer center: A longitudinal cohort study 1990–2005. BMC Cancer 8:131. doi:10.1186/1471-2407-8-131.
  • Nagtegaal, I. D., P. C. Allgood, S. W. Duffy, O. Kearins, E. O. Sullivan, N. Tappenden, et al. 2011. Prognosis and pathology of screen-detected carcinomas: How different are they? Cancer 117:1360–68. doi:10.1002/cncr.v117.7.
  • Olsson, Å., S. Borgquist, S. Butt, S. Zackrisson, G. Landberg, and J. Manjer. 2012. Tumour-related factors and prognosis in breast cancer detected by screening. The British Journal of Surgery 99:78–87. doi:10.1002/bjs.7757.
  • Pace, L. E., and N. L. Keating. 2014. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA 311:1327–35. doi:10.1001/jama.2014.1398.
  • Perry, N., M. Broeders, C. De Wolf, S. Törnberg, R. Holland, and L. Von Karsa. 2006. European guidelines for quality assurance in breast cancer screening and diagnosis, 4th ed. Luxembourg City, Luxembourg: Office for Official Publications of the European Communities.
  • Reeves, M. J., P. A. Newcomb, P. L. Remington, and P. M. Marcus. 1995. Determinants of breast cancer detection among Wisconsin (United States) women, 1988–90. Cancer Causes Control 6:103–11. doi:10.1007/BF00052770.
  • Tekkel, M., T. Veideman, A. Baburin, and M. Rahu. 2007. Use of mammography and Pap smear in Estonia, a country without organized cancer screening. International Journal of Public Health 52:109–16. doi:10.1007/s00038-007-6015-z.
  • Vanier, A., C. Leux, C. Allioux, S. Billon-Delacour, P. Lombrail, and F. Molinié. 2013. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France). Cancer Epidemiology 37:683–87. doi:10.1016/j.canep.2013.07.001.
  • Walters, S., C. Maringe, J. Butler, B. Rachet, P. Barrett-Lee, J. Bergh, et al. 2013. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000–2007: A population-based study. British Journal of Cancer 108:1195–208. doi:10.1038/bjc.2013.6.
  • Wishart, G. C., D. C. Greenberg, P. D. Britton, P. Chou, C. H. Brown, A. D. Purushotham, and S. W. Duffy. 2008. Screen-detected vs symptomatic breast cancer: Is improved survival due to stage migration alone? British Journal of Cancer 98:1741–44. doi:10.1038/sj.bjc.6604368.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.